Logo image of RHK.DE

RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis

FRA:RHK - Deutsche Boerse Ag - DE0007042301 - Common Stock - Currency: EUR

12.7  -0.1 (-0.78%)

Fundamental Rating

5

RHK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 25 industry peers in the Health Care Providers & Services industry. While RHK has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, RHK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year RHK was profitable.
RHK had a positive operating cash flow in the past year.
RHK had positive earnings in each of the past 5 years.
Each year in the past 5 years RHK had a positive operating cash flow.
RHK.DE Yearly Net Income VS EBIT VS OCF VS FCFRHK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.34%, RHK is in line with its industry, outperforming 52.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.35%, RHK is doing worse than 64.00% of the companies in the same industry.
The Return On Invested Capital of RHK (2.75%) is worse than 64.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RHK is below the industry average of 6.33%.
The last Return On Invested Capital (2.75%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.34%
ROE 3.35%
ROIC 2.75%
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
RHK.DE Yearly ROA, ROE, ROICRHK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

RHK has a Profit Margin of 2.72%. This is comparable to the rest of the industry: RHK outperforms 44.00% of its industry peers.
In the last couple of years the Profit Margin of RHK has declined.
RHK has a worse Operating Margin (3.04%) than 64.00% of its industry peers.
In the last couple of years the Operating Margin of RHK has declined.
The Gross Margin of RHK (66.44%) is better than 68.00% of its industry peers.
RHK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.04%
PM (TTM) 2.72%
GM 66.44%
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
RHK.DE Yearly Profit, Operating, Gross MarginsRHK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RHK is destroying value.
Compared to 1 year ago, RHK has about the same amount of shares outstanding.
Compared to 5 years ago, RHK has about the same amount of shares outstanding.
RHK has a better debt/assets ratio than last year.
RHK.DE Yearly Shares OutstandingRHK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RHK.DE Yearly Total Debt VS Total AssetsRHK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.03 indicates that RHK is not in any danger for bankruptcy at the moment.
The Altman-Z score of RHK (3.03) is better than 92.00% of its industry peers.
RHK has a debt to FCF ratio of 2.62. This is a good value and a sign of high solvency as RHK would need 2.62 years to pay back of all of its debts.
RHK has a Debt to FCF ratio of 2.62. This is amongst the best in the industry. RHK outperforms 92.00% of its industry peers.
RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, RHK belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.62
Altman-Z 3.03
ROIC/WACC0.43
WACC6.35%
RHK.DE Yearly LT Debt VS Equity VS FCFRHK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.23 indicates that RHK has no problem at all paying its short term obligations.
RHK has a Current ratio of 2.23. This is amongst the best in the industry. RHK outperforms 92.00% of its industry peers.
A Quick Ratio of 2.14 indicates that RHK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.14, RHK belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.14
RHK.DE Yearly Current Assets VS Current LiabilitesRHK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for RHK have decreased by -7.07% in the last year.
The Earnings Per Share has been growing slightly by 0.03% on average over the past years.
Looking at the last year, RHK shows a quite strong growth in Revenue. The Revenue has grown by 9.58% in the last year.
RHK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.12% yearly.
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%

3.2 Future

RHK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.28% yearly.
The Revenue is expected to grow by 5.94% on average over the next years.
EPS Next Y11.29%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
EPS Next 5Y12.28%
Revenue Next Year8.14%
Revenue Next 2Y6.08%
Revenue Next 3Y5.77%
Revenue Next 5Y5.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RHK.DE Yearly Revenue VS EstimatesRHK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
RHK.DE Yearly EPS VS EstimatesRHK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.17, RHK is valued on the expensive side.
RHK's Price/Earnings ratio is a bit more expensive when compared to the industry. RHK is more expensive than 60.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.35. RHK is around the same levels.
A Price/Forward Earnings ratio of 16.55 indicates a correct valuation of RHK.
The rest of the industry has a similar Price/Forward Earnings ratio as RHK.
The average S&P500 Price/Forward Earnings ratio is at 22.20. RHK is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.17
Fwd PE 16.55
RHK.DE Price Earnings VS Forward Price EarningsRHK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

RHK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RHK is cheaper than 100.00% of the companies in the same industry.
RHK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 14.87
EV/EBITDA 0.46
RHK.DE Per share dataRHK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.87
PEG (5Y)622.43
EPS Next 2Y10.72%
EPS Next 3Y10.65%

More info and screens

1

5. Dividend

5.1 Amount

RHK has a yearly dividend return of 0.78%, which is pretty low.
Compared to an average industry Dividend Yield of 2.77, RHK has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, RHK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RHK.DE Yearly Dividends per shareRHK.DE Yearly Dividends per shareYearly Dividends per share 2019 2023 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DP0%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
RHK.DE Yearly Income VS Free CF VS DividendRHK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

More info and screens

RHOEN-KLINIKUM AG

FRA:RHK (5/27/2025, 7:00:00 PM)

12.7

-0.1 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-07 2025-08-07
Inst Owners0.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap850.39M
Analysts45.71
Price Target14.28 (12.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.53%
Valuation
Industry RankSector Rank
PE 21.17
Fwd PE 16.55
P/S 0.53
P/FCF 14.87
P/OCF 6.66
P/B 0.66
P/tB 0.76
EV/EBITDA 0.46
EPS(TTM)0.6
EY4.72%
EPS(NY)0.77
Fwd EY6.04%
FCF(TTM)0.85
FCFY6.73%
OCF(TTM)1.91
OCFY15%
SpS23.83
BVpS19.35
TBVpS16.76
PEG (NY)1.87
PEG (5Y)622.43
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.35%
ROCE 3.34%
ROIC 2.75%
ROICexc 4.77%
ROICexgc 6.01%
OM 3.04%
PM (TTM) 2.72%
GM 66.44%
FCFM 3.58%
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
ROICexc(3y)3.1%
ROICexc(5y)2.62%
ROICexgc(3y)3.7%
ROICexgc(5y)3.13%
ROCE(3y)2.85%
ROCE(5y)2.44%
ROICexcg growth 3Y17.7%
ROICexcg growth 5Y-1.56%
ROICexc growth 3Y17.75%
ROICexc growth 5Y-1.75%
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.62
Debt/EBITDA 1.04
Cap/Depr 112.46%
Cap/Sales 4.41%
Interest Coverage 15.15
Cash Conversion 114.87%
Profit Quality 131.95%
Current Ratio 2.23
Quick Ratio 2.14
Altman-Z 3.03
F-Score6
WACC6.35%
ROIC/WACC0.43
Cap/Depr(3y)97.27%
Cap/Depr(5y)108.32%
Cap/Sales(3y)4.24%
Cap/Sales(5y)5.08%
Profit Quality(3y)86.55%
Profit Quality(5y)290.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
EPS Next Y11.29%
EPS Next 2Y10.72%
EPS Next 3Y10.65%
EPS Next 5Y12.28%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%
Revenue Next Year8.14%
Revenue Next 2Y6.08%
Revenue Next 3Y5.77%
Revenue Next 5Y5.94%
EBIT growth 1Y18.95%
EBIT growth 3Y16.29%
EBIT growth 5Y-3.2%
EBIT Next Year145.13%
EBIT Next 3Y44.3%
EBIT Next 5Y34.88%
FCF growth 1Y23.81%
FCF growth 3Y42.66%
FCF growth 5YN/A
OCF growth 1Y17.06%
OCF growth 3Y9.38%
OCF growth 5Y21.95%